Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based Therapy
Phuong K. Morrow(The University of Texas MD Anderson Cancer Center), Francisco J. Esteva(The University of Texas MD Anderson Cancer Center)
Cited by 211
Related Papers
PTEN, PIK3CA, p-AKT, and p-p70S6K Status
|American Journal Of Pathology|2010|285
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
|Breast Cancer Research|2010|137
LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer
|npj Breast Cancer|2020|33